Skip to main content
Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
24.16
+0.71 (3.03%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Eton Pharmaceuticals Revenue

In the year 2025, Eton Pharmaceuticals had annual revenue of $79.95M with 104.94% growth. Eton Pharmaceuticals had revenue of $21.28M in the quarter ending December 31, 2025, with 82.72% growth.

Revenue (ttm)
$79.95M
Revenue Growth
+104.94%
P/S Ratio
8.25
Revenue / Employee
$1,817,045
Employees
44
Market Cap
659.19M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202579.95M40.94M104.94%
Dec 31, 202439.01M7.37M23.29%
Dec 31, 202331.64M10.39M48.90%
Dec 31, 202221.25M-581.00K-2.66%
Dec 31, 202121.83M21.79M55,879.49%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tilray Brands 858.28M
Emergent BioSolutions 742.90M
Pacira BioSciences 726.41M
Amphastar Pharmaceuticals 719.89M
Esperion Therapeutics 403.14M
Ironwood Pharmaceuticals 296.15M
Canopy Growth 203.04M
Kamada 180.46M
Revenue Rankings

ETON News

More News